BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27713149)

  • 1. Human beta-defensin 3 contributes to the carcinogenesis of cervical cancer via activation of NF-κB signaling.
    Xu D; Zhang B; Liao C; Zhang W; Wang W; Chang Y; Shao Y
    Oncotarget; 2016 Nov; 7(46):75902-75913. PubMed ID: 27713149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The zinc finger protein ZNF268 is overexpressed in human cervical cancer and contributes to tumorigenesis via enhancing NF-κB signaling.
    Wang W; Guo M; Hu L; Cai J; Zeng Y; Luo J; Shu Z; Li W; Huang Z
    J Biol Chem; 2012 Dec; 287(51):42856-66. PubMed ID: 23091055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theanine from tea and its semi-synthetic derivative TBrC suppress human cervical cancer growth and migration by inhibiting EGFR/Met-Akt/NF-κB signaling.
    Liu J; Sun Y; Zhang H; Ji D; Wu F; Tian H; Liu K; Zhang Y; Wu B; Zhang G
    Eur J Pharmacol; 2016 Nov; 791():297-307. PubMed ID: 27612630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53.
    DasGupta T; Nweze EI; Yue H; Wang L; Jin J; Ghosh SK; Kawsar HI; Zender C; Androphy EJ; Weinberg A; McCormick TS; Jin G
    Oncotarget; 2016 May; 7(19):27430-44. PubMed ID: 27034006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-κB signaling in cervical cancer.
    Chang YW; Chen MW; Chiu CF; Hong CC; Cheng CC; Hsiao M; Chen CA; Wei LH; Su JL
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S687-95. PubMed ID: 25047463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human β-defensin 3 promotes NF-κB-mediated CCR7 expression and anti-apoptotic signals in squamous cell carcinoma of the head and neck.
    Mburu YK; Abe K; Ferris LK; Sarkar SN; Ferris RL
    Carcinogenesis; 2011 Feb; 32(2):168-74. PubMed ID: 21071608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-κB-dependent cyclin D1 signaling.
    Kuo SH; Chou CH; Cheng AL; Wang CW; Chen YH; Chen RJ
    Gynecol Oncol; 2012 Aug; 126(2):245-51. PubMed ID: 22564715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Actinin-4 induces the epithelial-to-mesenchymal transition and tumorigenesis via regulation of Snail expression and β-catenin stabilization in cervical cancer.
    An HT; Yoo S; Ko J
    Oncogene; 2016 Nov; 35(45):5893-5904. PubMed ID: 27065319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.
    Cao HZ; Liu XF; Yang WT; Chen Q; Zheng PS
    Cell Death Dis; 2017 Sep; 8(9):e3039. PubMed ID: 28880275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engeletin suppresses cervical carcinogenesis in vitro and in vivo by reducing NF-κB-dependent signaling.
    Bai H; Yin H
    Biochem Biophys Res Commun; 2020 May; 526(2):497-504. PubMed ID: 32241545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical Gene Delivery of the Antimicrobial Peptide, Human β-Defensin (HBD)-3, in a Mouse Model of Ascending Infection-Related Preterm Birth.
    Suff N; Karda R; Diaz JA; Ng J; Baruteau J; Perocheau D; Taylor PW; Alber D; Buckley SMK; Bajaj-Elliott M; Waddington SN; Peebles D
    Front Immunol; 2020; 11():106. PubMed ID: 32117260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to TNF‑α combined with TGF‑β induces carcinogenesis in vitro via NF-κB/Twist axis.
    Dong W; Sun S; Cao X; Cui Y; Chen A; Li X; Zhang J; Cao J; Wang Y
    Oncol Rep; 2017 Mar; 37(3):1873-1882. PubMed ID: 28098875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
    Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
    Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a cell-penetrating peptide domain from human beta-defensin 3 and characterization of its anti-inflammatory activity.
    Lee JY; Suh JS; Kim JM; Kim JH; Park HJ; Park YJ; Chung CP
    Int J Nanomedicine; 2015; 10():5423-34. PubMed ID: 26347021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-defensin 3 modulates macrophage activation and orientation during acute inflammatory response to Porphyromonas gingivalis lipopolysaccharide.
    Lyu J; Bian T; Chen B; Cui D; Li L; Gong L; Yan F
    Cytokine; 2017 Apr; 92():48-54. PubMed ID: 28092794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human cervical cancer cell growth by Salviolone is mediated via autophagy induction, cell migration and cell invasion suppression, G2/M cell cycle arrest and downregulation of Nf-kB/m-TOR/PI3K/AKT pathway.
    Zhang Y; Li G; Ji C
    J BUON; 2018; 23(6):1739-1744. PubMed ID: 30610802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-κB/APOBEC3B cascade.
    Jia QP; Yan CY; Zheng XR; Pan X; Cao X; Cao L
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):625-637. PubMed ID: 30631898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
    Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
    Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STC1 promotes cell apoptosis via NF-κB phospho-P65 Ser536 in cervical cancer cells.
    Pan X; Jiang B; Liu J; Ding J; Li Y; Sun R; Peng L; Qin C; Fang S; Li G
    Oncotarget; 2017 Jul; 8(28):46249-46261. PubMed ID: 28545028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
    Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.